PharmacyCodes



[1-(3-Methoxyphenyl)-2-propyl]amine en es it fr

Categoria

[1-(3-Methoxyphenyl)-2-propyl]amine Marchi, [1-(3-Methoxyphenyl)-2-propyl]amine Analoghi

[1-(3-Methoxyphenyl)-2-propyl]amine Marchi miscela

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

    • [1-(3-Methoxyphenyl)-2-propyl]amine Formula chimica

    C9H13N

    [1-(3-Methoxyphenyl)-2-propyl]amine RX link

    http://www.rxlist.com/cgi/generic3/adderallxr.htm

    [1-(3-Methoxyphenyl)-2-propyl]amine FDA foglio

    [1-(3-Methoxyphenyl)-2-propyl]amine DMS (foglio di materiale di sicurezza)

    [1-(3-Methoxyphenyl)-2-propyl]amine Sintesi di riferimento

    US Pat. 1.879.003, (1932)

    [1-(3-Methoxyphenyl)-2-propyl]amine Peso molecolare

    135.206 g/mol

    [1-(3-Methoxyphenyl)-2-propyl]amine Temperatura di fusione

    Volatizes slowly at room temperature

    [1-(3-Methoxyphenyl)-2-propyl]amine H2O Solubilita

    Leggermente

    [1-(3-Methoxyphenyl)-2-propyl]amine Stato

    Solid

    [1-(3-Methoxyphenyl)-2-propyl]amine LogP

    1.799

    [1-(3-Methoxyphenyl)-2-propyl]amine Forme di dosaggio

    Capsule

    [1-(3-Methoxyphenyl)-2-propyl]amine Indicazione

    Per il trattamento del Disturbo da Deficit di Attenzione con Iperattività (DDAI) e la narcolessia nei bambini.

    [1-(3-Methoxyphenyl)-2-propyl]amine Farmacologia

    Anfetamine e destroanfetamina, agenti sypathomimetic non catechloamine, sono utilizzati in combinazione per il trattamento di deficit di attenzione e iperattività (ADHD) o di narcolessia. Adderall è costituito da equivalente quantità di aspartato anfetamine, solfato di anfetamina, saccarato destroanfetamina e solfato destroanfetamina.

    [1-(3-Methoxyphenyl)-2-propyl]amine Assorbimento

    Esso forma molecole facilmente assorbito altamente liposolubile

    [1-(3-Methoxyphenyl)-2-propyl]amine Tossicita

    LD50 = 180 mg / kg (sc nel ratto). I sintomi più comuni che presentano visto sono agitazione, allucinazioni, comportamenti suicidari, e dolore toracico.

    [1-(3-Methoxyphenyl)-2-propyl]amine Informazioni paziente

    Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

    [1-(3-Methoxyphenyl)-2-propyl]amine Atto interessato organismi

    Gli esseri umani e altri mammiferi